Search
for
Sort by
Research 61–90 of 1000+
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- Comparative efficacy of oral dutasteride and low-, medium-, and high-dose oral minoxidil: a six-month prospective trichoscopic and clinical study
- Safety and tolerability of low-dose oral minoxidil in adolescents: A retrospective review
- Dose-Dependent Increases in Carotid Intima-Media Thickness Associated with Oral Minoxidil but Not Dutasteride in Healthy Young Males: A Randomized Controlled Pharmacological Trial
- Low-dose oral minoxidil for treatment of androgenetic alopecia and telogen effluvium in a pediatric population: A descriptive study
- Low-Dose Oral Minoxidil During Chemotherapy: A Review of the Mechanism and Current Evidence
- The Requirement to Monitor Low-dose Oral Minoxidil in the Management of Hair Loss
- Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review
- Evaluación de la seguridad de minoxidil oral a dosis bajas en el tratamiento de la alopecia
- A case of aromatase inhibitor‐induced alopecia successfully treated with low‐dose oral minoxidil
- The role of androgens in hormone replacement therapy
- Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential
- Differential association between cumulative dose of 5α-reductase inhibitors and mortality
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Characteristics of Hypertrichosis Induced by 24-week Low-dose (5 mg Daily) Oral Minoxidil in Male Pattern Hair Loss Treatment
- Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial
- Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Persistent or new symptoms 1 year after a single high dose of vitamin D3 in patients with moderate to severe COVID-19
- The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms
- Updates in Treatment for Androgenetic Alopecia
- Interventions for central serous chorioretinopathy: a network meta-analysis
- Alopecia Areata
- Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer
- Zinc as an ambivalent but potent modulator of murine hair growth in vivo- preliminary observations
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Cosmetic Considerations in Dark-Skinned Patients
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study